39215908|t|Postmortem Fatty Acid Abnormalities in the Cerebellum of Patients with Essential Tremor.
39215908|a|Fatty acids play many critical roles in brain function but have not been investigated in essential tremor (ET), a frequent movement disorder suspected to involve cerebellar dysfunction. Here, we report a postmortem comparative analysis of fatty acid profiles by gas chromatography in the cerebellar cortex from ET patients (n = 15), Parkinson's disease (PD) patients (n = 15) and Controls (n = 17). Phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylinositol (PI)/ phosphatidylserine (PS) were separated by thin-layer chromatography and analyzed separately. First, the total amounts of fatty acids retrieved from the cerebellar cortex were lower in ET patients compared with PD patients, including monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA). The diagnosis of ET was associated with lower cerebellar levels of saturated fatty acids (SFA) and PUFA (DHA and ARA) in the PE fraction specifically, but with a higher relative content of dihomo-gamma-linolenic acid (DGLA; 20:3 omega-6) in the PC fraction. In contrast, a diagnosis of PD was associated with higher absolute concentrations of SFA, MUFA and omega-6 PUFA in the PI + PS fractions. However, relative PI + PS contents of omega-6 PUFA were lower in both PD and ET patients. Finally, linear regression analyses showed that the omega-3:omega-6 PUFA ratio was positively associated with age of death, but inversely associated with insoluble alpha-synuclein. Although it remains unclear how these FA changes in the cerebellum are implicated in ET or PD pathophysiology, they may be related to an ongoing neurodegenerative process or to dietary intake differences. The present findings provide a window of opportunity for lipid-based therapeutic nutritional intervention.
39215908	11	35	Fatty Acid Abnormalities	Disease	MESH:D008067
39215908	39	42	the	Disease	
39215908	57	65	Patients	Species	9606
39215908	71	87	Essential Tremor	Disease	MESH:D020329
39215908	89	100	Fatty acids	Chemical	MESH:D005227
39215908	178	194	essential tremor	Disease	MESH:D020329
39215908	196	198	ET	Disease	MESH:D020329
39215908	212	229	movement disorder	Disease	MESH:D009069
39215908	251	273	cerebellar dysfunction	Disease	MESH:D002526
39215908	328	338	fatty acid	Chemical	MESH:D005227
39215908	373	376	the	Disease	
39215908	400	402	ET	Disease	MESH:D020329
39215908	403	411	patients	Species	9606
39215908	422	441	Parkinson's disease	Disease	MESH:D010300
39215908	443	445	PD	Disease	MESH:D010300
39215908	447	455	patients	Species	9606
39215908	488	507	Phosphatidylcholine	Chemical	MESH:D010713
39215908	509	511	PC	Chemical	MESH:D010713
39215908	514	538	phosphatidylethanolamine	Chemical	MESH:C483858
39215908	540	542	PE	Chemical	MESH:C483858
39215908	548	568	phosphatidylinositol	Chemical	MESH:D010716
39215908	570	572	PI	Chemical	MESH:D010716
39215908	575	593	phosphatidylserine	Chemical	MESH:D010718
39215908	595	597	PS	Chemical	MESH:D010718
39215908	675	678	the	Disease	
39215908	696	707	fatty acids	Chemical	MESH:D005227
39215908	723	726	the	Disease	
39215908	759	761	ET	Disease	MESH:D020329
39215908	762	770	patients	Species	9606
39215908	785	787	PD	Disease	MESH:D010300
39215908	788	796	patients	Species	9606
39215908	808	823	monounsaturated	Chemical	-
39215908	825	829	MUFA	Chemical	MESH:D005229
39215908	835	862	polyunsaturated fatty acids	Chemical	MESH:D005231
39215908	864	868	PUFA	Chemical	MESH:D005231
39215908	871	874	The	Disease	
39215908	888	890	ET	Disease	MESH:D020329
39215908	938	959	saturated fatty acids	Chemical	MESH:D005227
39215908	961	964	SFA	Chemical	MESH:D005227
39215908	970	974	PUFA	Chemical	MESH:D005231
39215908	976	979	DHA	Chemical	MESH:C027493
39215908	984	987	ARA	Chemical	MESH:D016718
39215908	992	995	the	Disease	
39215908	996	998	PE	Chemical	MESH:C483858
39215908	1060	1087	dihomo-gamma-linolenic acid	Chemical	MESH:D015126
39215908	1089	1093	DGLA	Chemical	MESH:D015126
39215908	1095	1107	20:3 omega-6	Chemical	-
39215908	1112	1115	the	Disease	
39215908	1116	1118	PC	Chemical	MESH:D010713
39215908	1157	1159	PD	Disease	MESH:D010300
39215908	1214	1217	SFA	Chemical	MESH:D005227
39215908	1219	1223	MUFA	Chemical	MESH:D005229
39215908	1228	1240	omega-6 PUFA	Chemical	-
39215908	1244	1247	the	Disease	
39215908	1248	1250	PI	Chemical	MESH:D010716
39215908	1253	1255	PS	Chemical	MESH:D010718
39215908	1285	1287	PI	Chemical	MESH:D010716
39215908	1290	1292	PS	Chemical	MESH:D010718
39215908	1305	1317	omega-6 PUFA	Chemical	-
39215908	1337	1339	PD	Disease	MESH:D010300
39215908	1344	1346	ET	Disease	MESH:D020329
39215908	1347	1355	patients	Species	9606
39215908	1405	1408	the	Disease	
39215908	1409	1416	omega-3	Chemical	-
39215908	1417	1429	omega-6 PUFA	Chemical	-
39215908	1474	1479	death	Disease	MESH:D003643
39215908	1521	1536	alpha-synuclein	Gene	6622
39215908	1576	1578	FA	Chemical	MESH:D005492
39215908	1590	1593	the	Disease	
39215908	1623	1625	ET	Disease	MESH:D020329
39215908	1629	1631	PD	Disease	MESH:D010300
39215908	1683	1700	neurodegenerative	Disease	MESH:D019636
39215908	1743	1746	The	Disease	
39215908	1800	1805	lipid	Chemical	MESH:D008055
39215908	Negative_Correlation	MESH:D005227	MESH:D020329
39215908	Positive_Correlation	MESH:D010718	MESH:D010300
39215908	Positive_Correlation	MESH:D005229	MESH:D010300
39215908	Negative_Correlation	MESH:C027493	MESH:D020329
39215908	Association	MESH:D005231	MESH:D010300
39215908	Association	MESH:C483858	MESH:D005231
39215908	Association	MESH:D005492	MESH:D019636
39215908	Negative_Correlation	MESH:D005231	MESH:D020329
39215908	Association	MESH:D010713	MESH:D015126
39215908	Negative_Correlation	MESH:D016718	MESH:D020329
39215908	Association	MESH:C483858	MESH:D016718
39215908	Positive_Correlation	MESH:D010716	MESH:D010300
39215908	Positive_Correlation	MESH:D005227	MESH:D010300
39215908	Association	MESH:C483858	MESH:D020329
39215908	Association	MESH:D005492	MESH:D020329
39215908	Association	MESH:D010713	MESH:D020329
39215908	Positive_Correlation	MESH:D015126	MESH:D020329
39215908	Association	MESH:C483858	MESH:D005227

